13F filer · CIK 1513038 ↗
Perkins Coie Trust Co
You are looking at Q1 2022. See the latest, Q3 2026 →
Reported value
$322.1M
−5.6% on the quarter before
Positions
265
18 new · 9 sold out
Top 10
38.7%
of the value
Est. gain
−$22.9M
on stocks held all quarter
Est. return
−6.9%
on those stocks since Q4 2021
Positions as of Mar 31, 2022, from Perkins Coie Trust Co's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 61% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2021. Striped tiles are options.
Largest buys
Since Q4 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Vanguard Mid Cap ETF~$9.2MNew · 0.0% → 2.9%+38,653 shares
- Vanguard Russell 1000 Growth ETF~$1.6MAdded · 3.1% → 3.5%+22,503 shares
- Apple~$1.1MAdded · 5.0% → 5.6%+6,198 shares
- Freeport-McMoRan~$392,000New · 0.0% → 0.1%+7,875 shares
- Vanguard Mid Cap ETF~$346,060Added · 6.9% → 6.9%+1,455 shares
- AT&T~$309,006Added · 0.7% → 0.8%+13,081 shares
- SentinelOne~$264,000New · 0.0% → 0.1%+6,829 shares
- Alphabet~$230,835Added · 2.2% → 2.3%+83 shares
- Target Corp~$227,039Added · 0.9% → 1.0%+1,070 shares
- Marriott International Inc~$215,510Added · 0.0% → 0.1%+1,228 shares
Largest sells
Since Q4 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares S&P Midcap 400 Growth~$4.9MSold out · 1.4% → 0.0%−57,420 shares
- Ishares S&P 500 Growth ETF~$1.6MCut · 5.1% → 4.5%−20,946 shares
- Microsoft~$736,512Cut · 7.0% → 6.5%−2,389 shares
- Costco Wholesale Corp~$233,791Cut · 0.3% → 0.3%−406 shares
- Ishares S&P Midcap 400 Growth~$231,509Cut · 1.6% → 1.5%−2,996 shares
- Pfizer Inc~$195,539Cut · 1.5% → 1.4%−3,777 shares
- Cvs Health Corp~$186,427Cut · 1.4% → 1.4%−1,842 shares
- Stryker Corp~$168,689Cut · 1.4% → 1.4%−631 shares
- Ishares Gold Trust Npv~$146,691Cut · 0.4% → 0.4%−3,983 shares
- Nike Inc Cl B~$145,179Cut · 0.5% → 0.4%−1,079 shares
Holdings
As of Mar 31, 2022. Changes are in shares against Dec 31, 2021, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vanguard Mid Cap ETFEQUITY - MIDCAP - ETF · shares +1.6% · price −6.6% | 6.9% | $22.3M | −$1.6M | ||||||||
| MicrosoftCOMMON STOCK · shares −3.4% · price −8.3% | 6.5% | $21.0M | −$1.9M | ||||||||
| AppleCOMMON STOCK · shares +6.4% · price −1.7% | 5.6% | $18.0M | −$287,208 | ||||||||
| Ishares S&P 500 Growth ETFEQUITY - LARGE CAP - ETF · shares −10% · price −8.7% | 4.5% | $14.4M | −$1.4M | ||||||||
| Vanguard Russell 1000 Growth ETFEQUITY - LARGE CAP - ETF · shares +17% · price −9.1% | 3.5% | $11.2M | −$967,794 | ||||||||
| Vanguard Mid Cap ETFEQUITY - MIDCAP - ETF · shares New | 2.9% | $9.2M | — | ||||||||
| AlphabetCOMMON STOCK · shares +3.2% · price −4.0% | 2.3% | $7.5M | −$303,835 | ||||||||
| Danaher CorpCOMMON STOCK · shares +0.2% · price −10.9% | 2.2% | $7.2M | −$875,146 | ||||||||
| Unitedhealth Group IncCOMMON STOCK · shares −0.6% · price +1.6% | 2.2% | $7.1M | +$108,172 | ||||||||
| Visa Inc.COMMON STOCK · shares +0.5% · price +2.3% | 2.1% | $6.6M | +$150,394 | ||||||||
| QualcommCOMMON STOCK · shares +2.0% · price −16.4% | 2.0% | $6.5M | −$1.3M | ||||||||
| Procter & Gamble CoCOMMON STOCK · shares −1.4% · price −6.6% | 1.9% | $6.2M | −$435,822 | ||||||||
| Home Depot IncCOMMON STOCK · shares −0.2% · price −27.9% | 1.9% | $6.0M | −$2.3M | ||||||||
| Pepsico IncCOMMON STOCK · shares −1.5% · price −3.7% | 1.8% | $5.8M | −$218,541 | ||||||||
| Charles Schwab CorpCOMMON STOCK · shares −1.7% · price +0.3% | 1.7% | $5.6M | +$14,377 | ||||||||
| CiscoCOMMON STOCK · shares −1.0% · price −12.0% | 1.6% | $5.2M | −$708,356 | ||||||||
| BlackRockCOMMON STOCK · shares −1.2% · price −16.5% | 1.6% | $5.0M | −$993,921 | ||||||||
| Accenture PlcCOMMON STOCK · shares −2.3% · price −18.6% | 1.5% | $4.9M | −$1.1M | ||||||||
| OracleCOMMON STOCK · shares −1.8% · price −5.1% | 1.5% | $4.8M | −$261,612 | ||||||||
| Ishares S&P Midcap 400 GrowthEQUITY - MIDCAP - ETF · shares −4.6% · price −9.4% | 1.5% | $4.8M | −$497,544 | ||||||||
| Union Pacific CorpCOMMON STOCK · shares −2.4% · price +8.4% | 1.5% | $4.7M | +$365,070 | ||||||||
| Walt Disney Company (The)COMMON STOCK · shares +1.9% · price −11.4% | 1.4% | $4.6M | −$582,724 | ||||||||
| Starbucks CorpCOMMON STOCK · shares +2.9% · price −22.2% | 1.4% | $4.5M | −$1.3M | ||||||||
| Stryker CorpCOMMON STOCK · shares −3.7% · price −0.0% | 1.4% | $4.4M | −$1,263 | ||||||||
| Cvs Health CorpCOMMON STOCK · shares −4.1% · price −1.9% | 1.4% | $4.4M | −$84,975 | ||||||||
| Total · 265 positions | 100% | $322.1M | −$22.9M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2021 to Q1 2022: 243 stocks held throughout, down $22.9M (−6.9%).
- Chevron Corp+$1.2M+39%
- Abbvie Inc+$724,353+20%
- Metlife Inc+$388,437+12%
- Union Pacific Corp+$365,070+8%
- Chubb Limited+$364,994+11%
- Ishares S&P 500 Growth ETF−$1.4M−9%
- PayPal−$1.6M−39%
- Vanguard Mid Cap ETF−$1.6M−7%
- Microsoft−$1.9M−8%
- Home Depot Inc−$2.3M−28%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 14, 2026 | $625.7M+4% | SEC ↗ |
| Q2 2026 | Jul 9, 2026 | $603.3M+16% | SEC ↗ |
| Q1 2026 | Apr 15, 2026 | $520.1M−3% | SEC ↗ |
| Q4 2025 | Jan 12, 2026 | $537.0M+1% | SEC ↗ |
| Q3 2025 | Oct 9, 2025 | $531.5M−9% | SEC ↗ |
| Q2 2025 | Jul 10, 2025 | $587.1M+33% | SEC ↗ |
| Q1 2025 | Apr 11, 2025 | $441.0M−3% | SEC ↗ |
| Q4 2024 | Jan 16, 2025 | $454.4M+1% | SEC ↗ |
| Q3 2024 | Oct 8, 2024 | $450.9M+5% | SEC ↗ |
| Q2 2024 | Jul 15, 2024 | $430.1M+1% | SEC ↗ |
| Q1 2024 | Apr 12, 2024 | $426.7M+8% | SEC ↗ |
| Q4 2023 | Jan 9, 2024 | $396.1M+12% | SEC ↗ |
| Q3 2023 | Oct 11, 2023 | $354.4M+1% | SEC ↗ |
| Q2 2023 | Jul 14, 2023 | $352.1M+5% | SEC ↗ |
| Q1 2023 | Apr 13, 2023 | $333.8M+7% | SEC ↗ |
| Q4 2022 | Jan 18, 2023 | $312.8M+20% | SEC ↗ |
| Q3 2022 | Oct 7, 2022 | $260.9M−5% | SEC ↗ |
| Q2 2022 | Jul 8, 2022 | $274.7M−15% | SEC ↗ |
| Q1 2022 | Apr 15, 2022 | $322.1M−6% | SEC ↗ |
| Q4 2021 | Jan 13, 2022 | $341.1M+7% | SEC ↗ |
| Q3 2021 | Oct 13, 2021 | $319.7M−2% | SEC ↗ |
| Q2 2021 | Jul 14, 2021 | $324.9M+8% | SEC ↗ |
| Q1 2021 | Apr 13, 2021 | $300.0M+2% | SEC ↗ |
| Q4 2020 | Jan 12, 2021 | $293.0M+17% | SEC ↗ |
| Q3 2020 | Oct 13, 2020 | $250.5M+3% | SEC ↗ |
| Q2 2020 | Jul 13, 2020 | $243.1M+24% | SEC ↗ |
| Q1 2020 | Apr 10, 2020 | $196.4M−20% | SEC ↗ |
| Q4 2019 | Jan 9, 2020 | $244.1M+8% | SEC ↗ |
| Q3 2019 | Oct 11, 2019 | $225.8M+3% | SEC ↗ |
| Q2 2019 | Jul 10, 2019 | $220.1M+2% | SEC ↗ |
| Q1 2019 | Apr 8, 2019 | $215.0M+13% | SEC ↗ |
| Q4 2018 | Jan 15, 2019 | $191.0M−11% | SEC ↗ |
| Q3 2018 | Oct 15, 2018 | $215.4M+6% | SEC ↗ |
| Q2 2018 | Jul 17, 2018 | $202.3M+0% | SEC ↗ |
| Q1 2018 | Apr 16, 2018 | $201.4M+1% | SEC ↗ |
| Q4 2017 | Jan 12, 2018 | $200.2M+4% | SEC ↗ |
| Q3 2017 | Oct 13, 2017 | $192.6M+4% | SEC ↗ |
| Q2 2017 | Jul 10, 2017 | $185.8M+9% | SEC ↗ |
| Q1 2017 | Apr 11, 2017 | $170.1M+3% | SEC ↗ |
| Q4 2016 | Jan 10, 2017 | $164.8M+5% | SEC ↗ |
| Q3 2016 | Oct 11, 2016 | $157.7M+4% | SEC ↗ |
| Q2 2016 | Jul 8, 2016 | $151.6M+3% | SEC ↗ |
| Q1 2016 | Apr 15, 2016 | $147.0M | SEC ↗ |